Skip to main content
. 2021 Oct 28;12:709329. doi: 10.3389/fgene.2021.709329

TABLE 1.

The relationship of CRC patients clinical feature and the DE-FLs model.

Expression
Total (n = 408) High (n = 205) Low (n = 203) p_value
Gender
 female 192 (47.1%) 99 (48.3%) 93 (45.8%) 0.687
 male 216 (52.9%) 106 (51.7%) 110 (54.2%)
Age (years) 0.138
 ≥ 60 290 (71.1%) 153 (74.6%) 137 (67.5%)
 <60 118 (28.9%) 52 (25.4%) 66 (32.5%)
Pathologic stage 0.592
 stage_Ⅰ 67 (16.4%) 32 (15.6%) 35 (17.2%)
 stage_Ⅱ 152 (37.3%) 74 (36.1%) 78 (38.4%)
 stage_Ⅲ 122 (29.9%) 61 (29.8%) 61 (30.0%)
 stage_Ⅳ 53 (13.0%) 32 (15.6%) 21 (10.3%)
 unknown 14 (3.4%) 6 (2.9%) 8 (3.8%)
T stage
 T1 9 (2.2%) 6 (2.9%) 3 (1.5%) 0.568
 T2 71 (17.4%) 32 (15.6%) 39 (19.2%)
 T3 290 (71.1%) 146 (71.2%) 144 (70.9%)
 T4 37 (9.1%) 20 (9.8%) 17 (8.4%)
 unknown 1 (0.2%) 1 (0.5%) 0 (0%)
M stage 0.174
 M0 302 (74.0%) 148 (72.2%) 154 (75.9%)
 M1 52 (12.7%) 32 (15.6%) 20 (9.9%)
 MX 45 (11.0%) 19 (9.3%) 26 (12.8%)
 unknown 9 (2.2%) 6 (2.9%) 3 (1.5%)
N stage 0.285
 N0 231 (56.6%) 112 (54.6%) 119 (58.6%)
 N1 92 (22.5%) 42 (20.5%) 50 (24.6%)
 N2 82 (20.1%) 49 (23.9%) 33 (16.3%)
 NX 2 (0.5%) 1 (0.5%) 1 (0.5%)
 unknown 1 (0.2%) 1 (0.5%) 0 (0%)